RAD-140 Testolone Research Overview
RAD-140, also known as Testolone, is a synthetic non-steroidal selective androgen receptor modulator. It is one of the most widely discussed compounds in SARMs research because it was designed to interact with androgen receptor signalling while showing a different tissue-selective profile from traditional androgenic compounds.
In research terms, RAD-140 is studied for androgen receptor binding, transcriptional signalling, anabolic marker pathways, tissue-selective receptor activation and comparative selectivity against other steroid hormone receptor systems.
RAD-140 is not a peptide. It is a small-molecule SARM researched through androgen receptor pharmacology. This separates it from peptide research compounds such as GHRH analogues, growth hormone secretagogues, GLP-1 receptor agonists and tissue matrix peptides.
The main scientific interest in RAD-140 is how a non-steroidal compound can activate androgen receptor pathways in a selective way. This makes it relevant to receptor biology, muscle and bone marker research, endocrine pathway studies and transcriptional regulation models.
What is RAD-140 Testolone
RAD-140 is commonly known as Testolone. It is a selective androgen receptor modulator, usually shortened to SARM.
Key research identifiers include:
Compound name: RAD-140
Common name: Testolone
Compound class: Selective androgen receptor modulator
Molecular formula: C20H16ClN5O2
Primary pathway: Androgen receptor signalling
Research focus: Receptor selectivity, anabolic marker pathways and tissue-selective androgen signalling
SARMs are designed to interact with androgen receptors. The androgen receptor is a nuclear receptor that can influence gene expression after ligand binding. When a compound binds to the androgen receptor, the receptor can change shape, move into the nucleus, interact with DNA response elements and influence transcription of androgen-responsive genes.
RAD-140 is studied because it belongs to the non-steroidal SARM category. This means it is structurally different from steroidal androgen compounds, while still being researched for androgen receptor interaction.
RAD-140 and androgen receptor signalling
The androgen receptor is central to RAD-140 research. It is a ligand-activated transcription factor, meaning it responds to compounds that bind to it and then influences gene expression.
In a simplified research model, androgen receptor signalling can involve:
ligand binding
receptor conformational change
release of heat shock proteins
receptor dimerisation
movement into the nucleus
binding to androgen response elements
recruitment of co-regulator proteins
gene transcription changes
marker-level pathway response
RAD-140 is studied because it can interact with this receptor system. The value of the compound in research comes from analysing how strongly it binds, how selectively it behaves, how transcriptional markers change and how tissue-specific readouts compare with other androgen receptor ligands.
The original preclinical characterisation paper reported RAD140 as having strong androgen receptor affinity and selectivity over other steroid hormone nuclear receptors. That makes receptor selectivity one of the most important themes in RAD-140 research.
Why RAD-140 is called a SARM
RAD-140 is called a SARM because it is part of the selective androgen receptor modulator category.
The word “selective” is important. It does not mean the compound only acts in one tissue or creates one simple outcome. It means researchers are interested in whether the compound can produce different receptor-mediated responses across different tissues or marker systems when compared with less selective androgenic compounds.
SARM research often studies:
androgen receptor binding
co-activator recruitment
tissue-selective marker response
anabolic marker expression
bone marker response
muscle marker models
prostate marker comparison
endocrine feedback
transcriptional activity
receptor selectivity
RAD-140 is one of the better-known compounds in this category because it has appeared in receptor affinity studies, preclinical tissue-selectivity work and broader discussions of non-steroidal androgen receptor modulators.
RAD-140 molecular structure and classification
RAD-140 is a small organic molecule rather than an amino acid sequence or peptide chain. Its molecular formula is C20H16ClN5O2.
This matters because SARMs are sometimes grouped with peptides on supplier websites, but chemically they are different. Peptides are built from amino acids linked by peptide bonds. RAD-140 is not built in that way.
A cleaner classification is:
RAD-140 is a non-steroidal small-molecule selective androgen receptor modulator.
It should not be described as:
a peptide
a growth hormone secretagogue
a GHRH analogue
a GLP-1 analogue
a myostatin inhibitor
a steroid hormone
Better wording includes:
selective androgen receptor modulator
non-steroidal SARM
androgen receptor ligand
small-molecule research compound
androgen receptor pathway research compound
Correct classification helps keep research education clear and avoids confusion between SARMs, peptide analogues, growth hormone pathway compounds and metabolic receptor agonists.
How RAD-140 works in research
RAD-140 research is based on androgen receptor activation. When a compound binds to the androgen receptor, the receptor can alter transcription of genes connected with androgen-responsive pathways.
In research models, scientists may examine:
binding affinity
receptor selectivity
transcriptional activation
co-regulator recruitment
gene expression markers
protein synthesis marker pathways
muscle tissue marker response
bone tissue marker response
prostate tissue marker comparison
endocrine feedback markers
The main research question is not simply whether RAD-140 activates the androgen receptor. It is how that activation compares across different tissue models, how selective the response appears, and which marker panels change under controlled conditions.
This is why RAD-140 is discussed in selective androgen receptor research rather than general steroid hormone research.
RAD-140 and tissue-selective research
Tissue selectivity is one of the biggest themes in SARM research. Traditional androgen receptor activation can affect many androgen-responsive tissues. SARMs are researched because they may show different activity profiles depending on tissue type, receptor context, metabolism, co-regulator environment and gene expression conditions.
RAD-140 research may compare:
muscle marker response
bone marker response
prostate marker response
neural tissue marker interest
endocrine feedback markers
liver enzyme marker panels
androgen-responsive gene expression
anabolic-to-androgenic marker ratios
This does not mean the compound has a single simple effect. Tissue selectivity is complex. A receptor can behave differently depending on ligand structure, cell type, co-regulator proteins, receptor density and metabolic environment.
RAD-140 is useful in this research area because it gives scientists a non-steroidal ligand for studying androgen receptor selectivity and tissue-dependent marker changes.
RAD-140 and muscle marker research
RAD-140 is often discussed in relation to muscle marker research because androgen receptor signalling is connected with anabolic pathway regulation.
In research settings, this may involve:
lean tissue marker panels
protein synthesis pathway markers
myogenic gene expression
nitrogen balance models
muscle fibre marker analysis
catabolic marker comparison
anabolic transcription patterns
androgen-responsive pathway studies
The correct research-focused wording is marker-based. RAD-140 should not be described through personal outcome claims. Its relevance comes from studying androgen receptor-mediated signalling and how that signalling influences anabolic marker pathways in controlled research models.
RAD-140 and bone marker research
Androgen receptor signalling is also connected with bone metabolism and skeletal marker pathways. Because RAD-140 is studied as an androgen receptor modulator, it may appear in research connected to bone mineral markers and tissue maintenance models.
Research topics may include:
bone formation markers
bone resorption markers
mineralisation-related markers
osteoblast pathway studies
skeletal tissue marker response
androgen receptor activity in bone models
comparative tissue selectivity
Bone research is one of the areas where SARM selectivity is often discussed. The aim is to understand how androgen receptor ligands influence skeletal markers compared with other tissue markers.
RAD-140 and endocrine feedback research
Androgen receptor signalling is part of a larger endocrine network. Because of this, RAD-140 research can also include endocrine feedback markers.
Study models may review:
luteinising hormone markers
follicle-stimulating hormone markers
testosterone pathway markers
sex hormone-binding globulin markers
feedback loop response
hypothalamic-pituitary-gonadal axis signalling
dose-response marker relationships in controlled models
This area is important because androgen receptor activation does not happen in isolation. Receptor activity can connect with feedback loops that regulate hormone signalling across the wider endocrine system.
In a research overview, RAD-140 should therefore be discussed not only as an androgen receptor ligand but also as a compound relevant to endocrine signalling interpretation.
RAD-140 and selectivity over other receptors
One important part of RAD-140 research is selectivity. A compound that binds strongly to the androgen receptor but shows weaker activity at other steroid hormone receptors may be useful in selectivity studies.
The preclinical RAD140 paper reported strong androgen receptor affinity and selectivity over other steroid hormone nuclear receptors, with progesterone receptor noted as the closest off-target receptor in that study.
This does not mean RAD-140 has no wider biological effects. It means that receptor profiling is an important part of the research discussion.
Selectivity research may include:
androgen receptor affinity
progesterone receptor comparison
glucocorticoid receptor comparison
mineralocorticoid receptor comparison
estrogen receptor comparison
transcriptional assay results
off-target receptor screening
ligand-receptor binding profiles
Understanding these comparisons helps researchers position RAD-140 within the broader SARM category.
RAD-140 compared with MK-677
RAD-140 and MK-677 are often discussed together online, but they are very different compounds.
RAD-140 is a selective androgen receptor modulator. It is studied through androgen receptor signalling.
MK-677, also known as Ibutamoren, is not a SARM. It is a growth hormone secretagogue researched through the ghrelin receptor / GHSR pathway.
The difference is important:
RAD-140: androgen receptor pathway
MK-677: ghrelin receptor / GHSR pathway
RAD-140: non-steroidal SARM
MK-677: non-peptide growth hormone secretagogue
RAD-140: androgen-responsive transcription markers
MK-677: GH axis and IGF-1 marker research
Both may appear in research compound categories, but they should not be described as the same type of compound.
RAD-140 compared with Ostarine and Ligandrol
RAD-140 is often discussed alongside other SARMs such as Ostarine and Ligandrol. These compounds all relate to androgen receptor research, but they are not identical.
Comparison research may focus on:
androgen receptor affinity
tissue-selective marker patterns
anabolic marker response
bone marker response
metabolic marker differences
endocrine feedback profiles
gene transcription signatures
binding and activation strength
RAD-140 is usually positioned as a strong androgen receptor research compound. Ostarine is often discussed as an earlier SARM research compound, while Ligandrol is frequently examined in relation to anabolic marker models and tissue-selective activity.
Each SARM should be studied as its own compound with its own structure, receptor profile and marker behaviour.
RAD-140 and laboratory interpretation
RAD-140 research should be interpreted through structured marker analysis. A single measurement rarely explains the full receptor pathway.
Important interpretation points include:
which tissue model is used
which receptor markers are measured
whether gene expression is assessed
whether endocrine markers are included
which comparator compound is used
whether time-course data is available
whether tissue-selective readouts are included
whether off-target receptor screening is included
Because androgen receptor signalling affects transcription, interpretation often requires looking at both receptor-level and marker-level data. This makes RAD-140 research more complex than simple product descriptions suggest.
RAD-140 and analytical testing
RAD-140 is a small-molecule research compound, so analytical testing is important for identity and purity review.
Testing methods may include:
HPLC purity analysis
LC-MS identity confirmation
NMR structure review
quantity testing
impurity profiling
batch documentation
COA review
A COA may provide information on purity, identity, batch number and analytical results depending on the supplier and testing method. HPLC is commonly used to assess purity, while LC-MS can support molecular identity by checking mass-related data.
For research-focused product education, analytical testing helps connect the compound name on the label with the material being supplied.
RAD-140 research summary
RAD-140 is best understood as a non-steroidal selective androgen receptor modulator researched for androgen receptor binding, receptor selectivity, transcriptional signalling and tissue-selective marker response.
Its key research themes include:
androgen receptor activation
SARM selectivity
muscle marker pathways
bone marker pathways
prostate marker comparison
endocrine feedback markers
gene transcription studies
off-target receptor profiling
analytical purity testing
small-molecule classification
RAD-140 is not a peptide and should not be grouped mechanistically with growth hormone secretagogues, GHRH analogues or GLP-1 receptor agonists. Its main scientific identity is androgen receptor pathway research.
Conclusion
RAD-140, also known as Testolone, is a synthetic non-steroidal selective androgen receptor modulator researched through androgen receptor signalling. It is a small-molecule compound with the molecular formula C20H16ClN5O2 and is best understood as an androgen receptor ligand rather than a peptide or growth hormone-related compound.
The main research interest in RAD-140 is its ability to interact with androgen receptor pathways in a selective way. This makes it relevant to receptor binding studies, transcriptional activation models, muscle marker research, bone marker research, prostate marker comparison, endocrine feedback studies and broader tissue-selective SARM research.
RAD-140 belongs in the SARM category because it is studied as a selective androgen receptor modulator. It should not be confused with MK-677, which acts through the ghrelin receptor pathway, or with peptide compounds such as GHRH analogues and growth hormone secretagogues.
For research interpretation, RAD-140 should be reviewed through receptor affinity, tissue-selective marker response, gene expression data, endocrine pathway markers and analytical identity testing. This gives a clearer scientific picture than broad online descriptions.
RAD-140 Testolone
View RAD-140 Testolone Research Compound at BioPlex Peptides ⟶
SARMs Research Compounds
View BioPlex Peptides SARMs research compounds ⟶
All discussion is presented strictly for educational and scientific research purposes only, supporting informed study, data interpretation, and responsible laboratory investigation.
